{"entity":{"type":"insider","cik":"0001457477","url":"/insider/0001457477","json_url":"/insider/0001457477.json","name":"Hallal David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":104,"n_filings":64,"first":"2009-06-12","last":"2026-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Hallal David","source":"filing","n_filings":64,"first_seen":"2009-06-12","last_seen":"2026-04-20"}],"transactions":[{"id":5956825,"accession":"0001104659-26-045581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-045581","line_url":"/filing/0001104659-26-045581#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30615.0,"shares_display":"30,615","price_per_share":49.5745,"price_display":"49.57","price_state":"stated","total_value":1517723.3175,"total_display":"1,517,723.32","total_whole":"1,517,723","shares_owned_after":1639034.0,"shares_owned_after_display":"1,639,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-20","scope":"insider"},{"id":5869294,"accession":"0001104659-26-004221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-004221","line_url":"/filing/0001104659-26-004221#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57450.0,"shares_display":"57,450","price_per_share":42.7,"price_display":"42.70","price_state":"stated","total_value":2453115.0,"total_display":"2,453,115.00","total_whole":"2,453,115","shares_owned_after":1541645.0,"shares_owned_after_display":"1,541,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":4618374,"accession":"0000950170-25-083410","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-25-083410","line_url":"/filing/0000950170-25-083410#line-6","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38228.0,"shares_display":"38,228","price_per_share":10.24,"price_display":"10.24","price_state":"stated","total_value":391454.72,"total_display":"391,454.72","total_whole":"391,455","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-06","filed_date":"2025-06-06","scope":"insider"},{"id":4618365,"accession":"0000950170-25-083410","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-083410","line_url":"/filing/0000950170-25-083410#line-4","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38227.0,"shares_display":"38,227","price_per_share":10.15,"price_display":"10.15","price_state":"stated","total_value":388004.05,"total_display":"388,004.05","total_whole":"388,004","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider"},{"id":4618358,"accession":"0000950170-25-083410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-083410","line_url":"/filing/0000950170-25-083410#line-2","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38227.0,"shares_display":"38,227","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":384945.89,"total_display":"384,945.89","total_whole":"384,946","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-06","scope":"insider"},{"id":6414826,"accession":"0000899243-22-033994","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033994","line_url":"/filing/0000899243-22-033994#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":8.45,"price_display":"8.45","price_state":"stated","total_value":5070000.0,"total_display":"5,070,000.00","total_whole":"5,070,000","shares_owned_after":138153.0,"shares_owned_after_display":"138,153","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-10-21","scope":"insider"},{"id":6089814,"accession":"0000899243-22-032297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-032297","line_url":"/filing/0000899243-22-032297#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":7.3523,"price_display":"7.35","price_state":"stated","total_value":2940920.0,"total_display":"2,940,920.00","total_whole":"2,940,920","shares_owned_after":720965.0,"shares_owned_after_display":"720,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-09-30","scope":"insider"},{"id":6318757,"accession":"0000899243-22-026519","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-026519","line_url":"/filing/0000899243-22-026519#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4227.0,"shares_display":"4,227","price_per_share":5.3295,"price_display":"5.33","price_state":"stated","total_value":22527.7965,"total_display":"22,527.80","total_whole":"22,528","shares_owned_after":2073662.0,"shares_owned_after_display":"2,073,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-21","scope":"insider"},{"id":6672109,"accession":"0001209191-22-036137","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-036137","line_url":"/filing/0001209191-22-036137#line-8","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1171.0,"shares_display":"1,171","price_per_share":19.51,"price_display":"19.51","price_state":"stated","total_value":22846.21,"total_display":"22,846.21","total_whole":"22,846","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-10","scope":"insider"},{"id":6672103,"accession":"0001209191-22-036137","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-036137","line_url":"/filing/0001209191-22-036137","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28444.0,"shares_display":"28,444","price_per_share":20.19291766277598,"price_display":"20.19","price_state":"stated","total_value":574367.35,"total_display":"574,367.35","total_whole":"574,367","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider","n_lines":3},{"id":6877416,"accession":"0000899243-22-021183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021183","line_url":"/filing/0000899243-22-021183#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65725.0,"shares_display":"65,725","price_per_share":3.6684,"price_display":"3.67","price_state":"stated","total_value":241105.59,"total_display":"241,105.59","total_whole":"241,106","shares_owned_after":2077889.0,"shares_owned_after_display":"2,077,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6263868,"accession":"0000899243-22-015395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015395","line_url":"/filing/0000899243-22-015395#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4227.0,"shares_display":"4,227","price_per_share":5.87,"price_display":"5.87","price_state":"stated","total_value":24812.49,"total_display":"24,812.49","total_whole":"24,812","shares_owned_after":2143614.0,"shares_owned_after_display":"2,143,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-22","scope":"insider"},{"id":6290632,"accession":"0000899243-22-010762","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-010762","line_url":"/filing/0000899243-22-010762#line-2","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25244.0,"shares_display":"25,244","price_per_share":7.3708,"price_display":"7.37","price_state":"stated","total_value":186068.4752,"total_display":"186,068.48","total_whole":"186,068","shares_owned_after":2147841.0,"shares_owned_after_display":"2,147,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-11","scope":"insider"},{"id":6290631,"accession":"0000899243-22-010762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-010762","line_url":"/filing/0000899243-22-010762#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40481.0,"shares_display":"40,481","price_per_share":7.5537,"price_display":"7.55","price_state":"stated","total_value":305781.3297,"total_display":"305,781.33","total_whole":"305,781","shares_owned_after":2173085.0,"shares_owned_after_display":"2,173,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-10","filed_date":"2022-03-11","scope":"insider"},{"id":6263251,"accession":"0000899243-22-003144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-003144","line_url":"/filing/0000899243-22-003144#line-1","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"Allovir, Inc.","issuer_ticker":"ALVR","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17100.0,"shares_display":"17,100","price_per_share":8.0052,"price_display":"8.01","price_state":"stated","total_value":136888.92,"total_display":"136,888.92","total_whole":"136,889","shares_owned_after":2213566.0,"shares_owned_after_display":"2,213,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":5262333,"accession":"0001209191-21-070993","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-070993","line_url":"/filing/0001209191-21-070993#line-3","is_derivative":false,"issuer_cik":"0001457477","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001457477","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":43.57,"price_display":"43.57","price_state":"stated","total_value":2178500.0,"total_display":"2,178,500.00","total_whole":"2,178,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-22","scope":"insider"},{"id":3108019,"accession":"0000899866-16-000339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000339","line_url":"/filing/0000899866-16-000339#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":332.0,"shares_display":"332","price_per_share":137.14,"price_display":"137.14","price_state":"stated","total_value":45530.48,"total_display":"45,530.48","total_whole":"45,530","shares_owned_after":189266.0,"shares_owned_after_display":"189,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-08","filed_date":"2016-08-10","scope":"insider"},{"id":2719131,"accession":"0000899866-16-000286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-16-000286","line_url":"/filing/0000899866-16-000286","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1414.0,"shares_display":"1,414","price_per_share":135.87817538896746,"price_display":"135.88","price_state":"stated","total_value":192131.74,"total_display":"192,131.74","total_whole":"192,132","shares_owned_after":189632.0,"shares_owned_after_display":"189,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider","n_lines":2},{"id":2863377,"accession":"0000899866-16-000265","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-16-000265","line_url":"/filing/0000899866-16-000265","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2014.0,"shares_display":"2,014","price_per_share":138.92765640516384,"price_display":"138.93","price_state":"stated","total_value":279800.3,"total_display":"279,800.30","total_whole":"279,800","shares_owned_after":191026.0,"shares_owned_after_display":"191,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-01","scope":"insider","n_lines":2},{"id":2235908,"accession":"0000899866-16-000245","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899866-16-000245","line_url":"/filing/0000899866-16-000245","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3946.0,"shares_display":"3,946","price_per_share":138.05439432336544,"price_display":"138.05","price_state":"stated","total_value":544762.64,"total_display":"544,762.64","total_whole":"544,763","shares_owned_after":173026.0,"shares_owned_after_display":"173,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-08","scope":"insider","n_lines":3},{"id":2235830,"accession":"0000899866-16-000245","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899866-16-000245","line_url":"/filing/0000899866-16-000245","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6722.0,"shares_display":"6,722","price_per_share":141.63097292472477,"price_display":"141.63","price_state":"stated","total_value":952043.4,"total_display":"952,043.40","total_whole":"952,043","shares_owned_after":178462.0,"shares_owned_after_display":"178,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-05","filed_date":"2016-02-08","scope":"insider","n_lines":6},{"id":2235708,"accession":"0000899866-16-000245","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-16-000245","line_url":"/filing/0000899866-16-000245","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":629.0,"shares_display":"629","price_per_share":143.82971383147853,"price_display":"143.83","price_state":"stated","total_value":90468.89,"total_display":"90,468.89","total_whole":"90,469","shares_owned_after":142568.0,"shares_owned_after_display":"142,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-04","filed_date":"2016-02-08","scope":"insider","n_lines":2},{"id":8837254,"accession":"0000899866-15-000153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000153","line_url":"/filing/0000899866-15-000153#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329.0,"shares_display":"329","price_per_share":190.01,"price_display":"190.01","price_state":"stated","total_value":62513.29,"total_display":"62,513.29","total_whole":"62,513","shares_owned_after":143187.0,"shares_owned_after_display":"143,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-07","filed_date":"2015-08-11","scope":"insider"},{"id":8913221,"accession":"0000899866-15-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000146","line_url":"/filing/0000899866-15-000146#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":612.0,"shares_display":"612","price_per_share":196.52,"price_display":"196.52","price_state":"stated","total_value":120270.24,"total_display":"120,270.24","total_whole":"120,270","shares_owned_after":143516.0,"shares_owned_after_display":"143,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-04","filed_date":"2015-08-05","scope":"insider"},{"id":8686766,"accession":"0000899866-15-000069","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-15-000069","line_url":"/filing/0000899866-15-000069#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":730.0,"shares_display":"730","price_per_share":180.34,"price_display":"180.34","price_state":"stated","total_value":131648.2,"total_display":"131,648.20","total_whole":"131,648","shares_owned_after":132858.0,"shares_owned_after_display":"132,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider"},{"id":8788303,"accession":"0000899866-15-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000048","line_url":"/filing/0000899866-15-000048#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1980.0,"shares_display":"1,980","price_per_share":171.15,"price_display":"171.15","price_state":"stated","total_value":338877.0,"total_display":"338,877.00","total_whole":"338,877","shares_owned_after":124033.0,"shares_owned_after_display":"124,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-12","scope":"insider"},{"id":8556139,"accession":"0000899866-15-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000029","line_url":"/filing/0000899866-15-000029#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2920.0,"shares_display":"2,920","price_per_share":173.93,"price_display":"173.93","price_state":"stated","total_value":507875.6,"total_display":"507,875.60","total_whole":"507,876","shares_owned_after":126013.0,"shares_owned_after_display":"126,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-09","scope":"insider"},{"id":8788302,"accession":"0000899866-15-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000013","line_url":"/filing/0000899866-15-000013#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":608.0,"shares_display":"608","price_per_share":174.38,"price_display":"174.38","price_state":"stated","total_value":106023.04,"total_display":"106,023.04","total_whole":"106,023","shares_owned_after":117243.0,"shares_owned_after_display":"117,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-05","scope":"insider"},{"id":8788301,"accession":"0000899866-15-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000013","line_url":"/filing/0000899866-15-000013#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":765.0,"shares_display":"765","price_per_share":174.02,"price_display":"174.02","price_state":"stated","total_value":133125.3,"total_display":"133,125.30","total_whole":"133,125","shares_owned_after":117851.0,"shares_owned_after_display":"117,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-03","filed_date":"2015-02-05","scope":"insider"},{"id":6597719,"accession":"0000899866-14-000273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000273","line_url":"/filing/0000899866-14-000273#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5494.0,"shares_display":"5,494","price_per_share":182.03,"price_display":"182.03","price_state":"stated","total_value":1000072.82,"total_display":"1,000,072.82","total_whole":"1,000,073","shares_owned_after":113122.0,"shares_owned_after_display":"113,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-18","filed_date":"2014-12-19","scope":"insider"},{"id":6777405,"accession":"0000899866-14-000238","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899866-14-000238","line_url":"/filing/0000899866-14-000238","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":190.00955733333333,"price_display":"190.01","price_state":"stated","total_value":5700286.72,"total_display":"5,700,286.72","total_whole":"5,700,287","shares_owned_after":132952.0,"shares_owned_after_display":"132,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider","n_lines":2},{"id":6627281,"accession":"0000899866-14-000179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000179","line_url":"/filing/0000899866-14-000179#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1349.0,"shares_display":"1,349","price_per_share":158.0,"price_display":"158.00","price_state":"stated","total_value":213142.0,"total_display":"213,142.00","total_whole":"213,142","shares_owned_after":118616.0,"shares_owned_after_display":"118,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-04","filed_date":"2014-08-05","scope":"insider"},{"id":6568480,"accession":"0000899866-14-000046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899866-14-000046","line_url":"/filing/0000899866-14-000046","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1610.0,"shares_display":"1,610","price_per_share":155.56552795031055,"price_display":"155.57","price_state":"stated","total_value":250460.5,"total_display":"250,460.50","total_whole":"250,461","shares_owned_after":113975.0,"shares_owned_after_display":"113,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-02-10","scope":"insider","n_lines":2},{"id":6568474,"accession":"0000899866-14-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-14-000046","line_url":"/filing/0000899866-14-000046#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10.0,"shares_display":"10","price_per_share":156.95,"price_display":"156.95","price_state":"stated","total_value":1569.5,"total_display":"1,569.50","total_whole":"1,570","shares_owned_after":113965.0,"shares_owned_after_display":"113,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-06","filed_date":"2014-02-10","scope":"insider"},{"id":6854270,"accession":"0000899866-14-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-14-000028","line_url":"/filing/0000899866-14-000028#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2390.0,"shares_display":"2,390","price_per_share":153.63,"price_display":"153.63","price_state":"stated","total_value":367175.7,"total_display":"367,175.70","total_whole":"367,176","shares_owned_after":105830.0,"shares_owned_after_display":"105,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-02-05","scope":"insider"},{"id":6854265,"accession":"0000899866-14-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000028","line_url":"/filing/0000899866-14-000028#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001457477","owner_name":"Hallal David","owner_display_name":"Hallal David","owner_url":"/insider/0001457477","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":729.0,"shares_display":"729","price_per_share":157.14,"price_display":"157.14","price_state":"stated","total_value":114555.06,"total_display":"114,555.06","total_whole":"114,555","shares_owned_after":108220.0,"shares_owned_after_display":"108,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-05","scope":"insider"}],"collapsed":true,"next_cursor":"2014-02-03|6854265","ledger_fault":false,"count":{"value":104,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":104,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":104},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001727196","name":"Scholar Rock Holding Corp","url":"/issuer/0001727196","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2026-01-15","last_seen":"2026-04-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001808865","name":"iTeos Therapeutics, Inc.","url":"/issuer/0001808865","role":"Director","n_filings":3,"first_seen":"2021-12-22","last_seen":"2025-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001754068","name":"Allovir, Inc.","url":"/issuer/0001754068","role":"Director, Ten percent owner","n_filings":7,"first_seen":"2022-01-25","last_seen":"2022-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Director, Officer (CEO)","n_filings":52,"first_seen":"2009-06-12","last_seen":"2016-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001457477","retrieved_at":"2026-08-23T22:13:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}